Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Bullboard Posts
Comment by Bigmac4000on Jun 05, 2020 4:28pm
110 Views
Post# 31118328

RE:RE:I guess it will close below $7 today

RE:RE:I guess it will close below $7 todayTo give you an idea, 350% wouldn't get most people their money back with FSD. Some people bought in around 94 cents or $189 post RS. It would have to go up 2700% to break even. Does that answer why people are so upset? That's at $7. Imagine at $4 like it was Tuesday. There is a lot of jaded people tied up in FSD.
Sandles wrote: Give us a heads up after your next entry please (obviously you don't want to say while you are loading as that might jump share price - being a financial guru capable of pickling tops and bottoms with people following your every move).

But seriously, I would like to know when you think is good entry. It's one thing to crow about entry and exit after the fact on the boards -- I have no way of validating what you say is true about your financial prowess. Please let me know your next ong call as you seem to know how to play this well (alegedly).


P.S. long Valeo Pharma steady in-licensing (not a developer, so no real risk), they sold portfolio for 350% return to shareholders to Valient in 2015, and have built again with some great portfolio additions in pipeline, that is a rinse and repeat scenario over months and years though, but steady way; see https://technologymarketwatch.com/vph.htm good read.


Bullboard Posts